Longcor Jarrod 4
4 · Cellectar Biosciences, Inc. · Filed Jan 18, 2023
Insider Transaction Report
Form 4
Longcor Jarrod
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2023-01-17+144,000→ 144,000 totalExercise: $1.68Exp: 2033-01-17→ Common Stock (144,000 underlying)
Footnotes (1)
- [F1]This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.